Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

164.05  +0.11 (+0.07%)

After market: 164.05 0 (0%)

Fundamental Rating

5

MYRG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 51 industry peers in the Construction & Engineering industry. No worries on liquidiy or solvency for MYRG as it has an excellent financial health rating, but there are worries on the profitability. MYRG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MYRG had positive earnings in the past year.
MYRG had a positive operating cash flow in the past year.
In the past 5 years MYRG has always been profitable.
Each year in the past 5 years MYRG had a positive operating cash flow.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets (2.28%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 6.31%, MYRG is in line with its industry, outperforming 54.90% of the companies in the same industry.
With a Return On Invested Capital value of 5.07%, MYRG perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
MYRG had an Average Return On Invested Capital over the past 3 years of 8.30%. This is significantly below the industry average of 16.96%.
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROIC 5.07%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MYRG's Profit Margin of 1.02% is in line compared to the rest of the industry. MYRG outperforms 45.10% of its industry peers.
MYRG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.71%, MYRG is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of MYRG has declined.
The Gross Margin of MYRG (8.90%) is worse than 68.63% of its industry peers.
MYRG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MYRG is destroying value.
MYRG has less shares outstanding than it did 1 year ago.
MYRG has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYRG has a worse debt to assets ratio.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.53 indicates that MYRG is not in any danger for bankruptcy at the moment.
MYRG has a Altman-Z score of 4.53. This is in the better half of the industry: MYRG outperforms 72.55% of its industry peers.
The Debt to FCF ratio of MYRG is 0.90, which is an excellent value as it means it would take MYRG, only 0.90 years of fcf income to pay off all of its debts.
MYRG's Debt to FCF ratio of 0.90 is amongst the best of the industry. MYRG outperforms 82.35% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that MYRG is not too dependend on debt financing.
MYRG's Debt to Equity ratio of 0.15 is fine compared to the rest of the industry. MYRG outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Altman-Z 4.53
ROIC/WACC0.48
WACC10.48%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.31. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.31, MYRG perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
MYRG has a Quick Ratio of 1.31. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
MYRG's Quick ratio of 1.31 is in line compared to the rest of the industry. MYRG outperforms 58.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MYRG have decreased strongly by -27.52% in the last year.
Measured over the past years, MYRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.67% on average per year.
MYRG shows a decrease in Revenue. In the last year, the revenue decreased by -7.33%.
The Revenue has been growing by 10.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%

3.2 Future

MYRG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.88% yearly.
MYRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.60% yearly.
EPS Next Y91.38%
EPS Next 2Y50.9%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue Next Year1.69%
Revenue Next 2Y3.58%
Revenue Next 3Y6.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 43.86, MYRG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as MYRG.
When comparing the Price/Earnings ratio of MYRG to the average of the S&P500 Index (26.60), we can say MYRG is valued expensively.
MYRG is valuated rather expensively with a Price/Forward Earnings ratio of 21.13.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYRG is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.43. MYRG is around the same levels.
Industry RankSector Rank
PE 43.86
Fwd PE 21.13
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MYRG's Enterprise Value to EBITDA ratio is in line with the industry average.
MYRG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.61
EV/EBITDA 22.13
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 39.88% in the coming years.
PEG (NY)0.48
PEG (5Y)5.06
EPS Next 2Y50.9%
EPS Next 3Y39.88%

More info and screens

0

5. Dividend

5.1 Amount

MYRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (5/20/2025, 8:19:13 PM)

After market: 164.05 0 (0%)

164.05

+0.11 (+0.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners100.45%
Inst Owner Change-1.95%
Ins Owners1.56%
Ins Owner Change2.83%
Market Cap2.65B
Analysts85
Price Target162.35 (-1.04%)
Short Float %5.7%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.89%
Min EPS beat(2)18.63%
Max EPS beat(2)39.15%
EPS beat(4)4
Avg EPS beat(4)56.53%
Min EPS beat(4)18.63%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)26.57%
EPS beat(12)7
Avg EPS beat(12)22.39%
EPS beat(16)11
Avg EPS beat(16)20.01%
Revenue beat(2)1
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)3.99%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)11
Avg Revenue beat(16)3%
PT rev (1m)4.85%
PT rev (3m)-15.19%
EPS NQ rev (1m)4.52%
EPS NQ rev (3m)11.3%
EPS NY rev (1m)5.68%
EPS NY rev (3m)4.16%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)-1.2%
Valuation
Industry RankSector Rank
PE 43.86
Fwd PE 21.13
P/S 0.78
P/FCF 26.61
P/OCF 16.27
P/B 4.83
P/tB 7.33
EV/EBITDA 22.13
EPS(TTM)3.74
EY2.28%
EPS(NY)7.76
Fwd EY4.73%
FCF(TTM)6.16
FCFY3.76%
OCF(TTM)10.08
OCFY6.15%
SpS209.44
BVpS33.99
TBVpS22.37
PEG (NY)0.48
PEG (5Y)5.06
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROCE 7.36%
ROIC 5.07%
ROICexc 5.14%
ROICexgc 6.79%
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
FCFM 2.94%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score4
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Debt/EBITDA 0.69
Cap/Depr 96.44%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 132.09%
Profit Quality 287.28%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 4.53
F-Score4
WACC10.48%
ROIC/WACC0.48
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
EPS Next Y91.38%
EPS Next 2Y50.9%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%
Revenue Next Year1.69%
Revenue Next 2Y3.58%
Revenue Next 3Y6.6%
Revenue Next 5YN/A
EBIT growth 1Y-52.55%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year377.04%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y-1.05%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y-11.17%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%